Labcorp Holdings
Labcorp is a global life sciences company that provides comprehensive laboratory services to support clinical decision-making and drug development. The company operates an extensive diagnostic network and provides critical support for the majority of new FDA-approved drugs through its research and clinical trial capabilities. Its value proposition centers on integrating large-scale diagnostic data with drug development insights to improve patient outcomes and accelerate medical innovation.
Financials
Based on Q1 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
Diagnostics Laboratories (Dx)
primaryProvides a comprehensive menu of routine and specialty testing through a vast network of primary and specialty laboratories. It focuses on high-growth areas such as oncology, women’s health, autoimmune disease, and neurology while offering digital tools for providers and patients.
Labcorp OnDemand, Labcorp Patient, Labcorp Diagnostic Assistant, Test Finder, Digital Pathology Solutions
Physicians, Health Systems, Managed Care Organizations, Employers, Patients
Biopharma Laboratory Services (BLS)
majorOffers end-to-end drug development solutions ranging from early-stage research and safety assessment to global clinical trial execution. It leverages a global network of central laboratories to support pharmaceutical and biotechnology companies in bringing new therapies to market.
Labcorp Global Trial Connect, Early Development Research Laboratories, Central Laboratory Services, Companion Diagnostics (CDx), Bioanalytical Testing Services
Pharmaceutical companies, Biotechnology companies, Medical Device companies, Contract Research Organizations (CROs)
Segment Financials
Diagnostics — Labor and Related Expense
View metricDiagnostics — Revenue
View metricDiagnostics — Operating Income
View metricBiopharma Laboratory Services — Freight
View metricBiopharma Laboratory Services — Revenue
View metricBiopharma Laboratory Services — Labor and Related Expense
View metricBusiness Overview
Competitive Position
A leading global provider of laboratory services with a dominant position in the U.S. clinical testing market and a significant role in supporting global drug development.
Geographies
United States, Canada, Europe, Asia
Customer Segments
Healthcare Providers, Biopharmaceutical Companies, Government Agencies, Individual Consumers
Upstream Dependencies
Laboratory equipment manufacturers, Chemical and reagent suppliers, IT and cloud infrastructure providers, Logistics and transportation services
Downstream Customers
Hospitals and health systems, Biopharmaceutical R&D departments, Health insurance payers, Retail healthcare consumers
Competitors & Partners
Competitors
Quest Diagnostics
DGX
Primary competitor in independent clinical laboratory services
IQVIA
IQV
Competitor in clinical trial and biopharma services
Icon
ICLR
Competitor in clinical research and laboratory services
Charles River Laboratories
CRL
Competitor in early-stage drug development and safety assessment
Natera, Inc.
NTRA
Competitor in NIPT and carrier screening
Partners
Project HOPE
Charitable partner for broadening rural healthcare access
American Red Cross
Disaster relief partner
Labcorp Holdings FAQ
Common questions about Labcorp Holdings
Labcorp is a global life sciences company that provides comprehensive laboratory services to support clinical decision-making and drug development. The company operates an extensive diagnostic network and provides critical support for the majority of new FDA-approved drugs through its research and clinical trial capabilities. Its value proposition centers on integrating large-scale diagnostic data with drug development insights to improve patient outcomes and accelerate medical innovation.
Labcorp Holdings (LH) has a market capitalization of $21.0B and trades on NYSE.
Labcorp Holdings generated $14.1B in trailing twelve-month revenue with net income of $941.5M, representing a net margin of 6.7%. Gross margin stands at 28.8%, with free cash flow of $1.4B. These figures are based on the Q1 2026 filing.
Labcorp Holdings's key competitors include Quest Diagnostics, IQVIA, ICON plc, and others. These companies compete in similar markets and product categories.
Labcorp Holdings has approximately 67,000 employees.